Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
antihypertensive agent |
| gptkbp:ATCCode |
C02CC01
|
| gptkbp:CASNumber |
56-53-1
|
| gptkbp:chemicalFormula |
C10H13N3
|
| gptkbp:discoveredIn |
1950s
|
| https://www.w3.org/2000/01/rdf-schema#label |
debrisoquine
|
| gptkbp:IUPACName |
2-(3,4-dihydro-1H-isoquinolin-2-yl)guanidine
|
| gptkbp:metabolism |
gptkb:CYP2D6
|
| gptkbp:molecularWeight |
191.23 g/mol
|
| gptkbp:sideEffect |
dizziness
fatigue hypotension |
| gptkbp:substrate |
gptkb:CYP2D6
|
| gptkbp:synonym |
2-(3,4-dihydroisoquinolin-2-yl)guanidine
Debrisoquin Debrisoquine sulfate |
| gptkbp:usedFor |
hypertension
|
| gptkbp:usedIn |
phenotyping of CYP2D6 activity
|
| gptkbp:bfsParent |
gptkb:debrisoquine_4-hydroxylase
|
| gptkbp:bfsLayer |
6
|